about
The immunopathology of sepsis: pathogen recognition, systemic inflammation, the compensatory anti-inflammatory response, and regulatory T cellsM1 and M2 immune activation in Parkinson's Disease: Foe and ally?Toll-like receptors in pathophysiology of liver diseasesCurrent understanding of immunity to Trypanosoma cruzi infection and pathogenesis of Chagas diseaseThe M1 and M2 paradigm of macrophage activation: time for reassessmentPromising therapies for treatment of nonalcoholic steatohepatitis.Inhibitory effect of tanshinone IIA on rat hepatic stellate cellsThe cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities.Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis.Microglial p38α MAPK is a key regulator of proinflammatory cytokine up-regulation induced by toll-like receptor (TLR) ligands or beta-amyloid (Aβ)Inflammatory mediator release from primary rhesus microglia in response to Borrelia burgdorferi results from the activation of several receptors and pathwaysToll-like receptor activation by helminths or helminth products to alleviate inflammatory bowel diseaseDUSP3 Genetic Deletion Confers M2-like Macrophage-Dependent Tolerance to Septic ShockAbsence of toll-like receptor 4 (TLR4) extends survival in the hSOD1 G93A mouse model of amyotrophic lateral sclerosis.Inhibition of myeloid differentiation factor 88 signaling mediated by histidine-grafted poly(β-amino ester) ester nanovector induces donor-specific liver allograft tolerance.Toll-like receptors in liver fibrosis: cellular crosstalk and mechanismsThe role of pattern recognition receptors in the innate recognition of Candida albicans.Chardonnay Grape Seed Flour Ameliorates Hepatic Steatosis and Insulin Resistance via Altered Hepatic Gene Expression for Oxidative Stress, Inflammation, and Lipid and Ceramide Synthesis in Diet-Induced Obese MiceA critical role of toll-like receptor 4 (TLR4) and its' in vivo ligands in basal radio-resistance.SARS Coronavirus Papain-Like Protease Inhibits the TLR7 Signaling Pathway through Removing Lys63-Linked Polyubiquitination of TRAF3 and TRAF6.Study on the inflammatory intervention of erythropoietin on NECToll-like receptor signaling in liver regeneration, fibrosis and carcinogenesisNovel toll-like receptor 2 ligands for targeted pancreatic cancer imaging and immunotherapy.Studying the Effect of Downregulating Autophagy-Related Gene LC3 on TLR3 Apoptotic Pathway Mediated by dsRNA in Hepatocellular Carcinoma Cells.Signaling via tumor necrosis factor receptor 1 but not Toll-like receptor 2 contributes significantly to hydrosalpinx development following Chlamydia muridarum infection.C-type lectin receptor-induced NF-κB activation in innate immune and inflammatory responses.Expression of surface and intracellular Toll-like receptors by mature mast cells.HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammation.Immunomodulatory properties of antifungal agents on phagocytic cells.Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut.Pattern recognition receptors: sentinels in innate immunity and targets of new vaccine adjuvants.The role of heat shock proteins in antigen cross presentation.The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension.C-type lectin-like receptors of the dectin-1 cluster: ligands and signaling pathways.Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis.Toll-like receptor signaling in neonatal sepsis and inflammation: a matter of orchestration and conditioning.Mesenchymal stem cell therapy for cardiac inflammation: immunomodulatory properties and the influence of toll-like receptors.Microglia receptors and their implications in the response to amyloid β for Alzheimer's disease pathogenesis.Role of innate immune response in non-alcoholic Fatty liver disease: metabolic complications and therapeutic tools.Rational design of peptide derivatives for inhibition of MyD88-mediated toll-like receptor signaling in human peripheral blood mononuclear cells and epithelial cells exposed to Francisella tularensis.
P2860
Q27022093-41DB1678-18C7-4848-AB8F-F0E8AF4A51D0Q27024667-42291696-9430-4847-A84C-7F56BB70F498Q28070077-5FE59F7C-59F2-454D-B0FD-AD8B78CC0B19Q28391025-FA6AA35E-AEEB-4B93-A27C-9992B313EB95Q29615845-F5B8E874-0705-47CA-ADCF-A7C6532AB4FFQ30248578-A3DBBBE3-3FC7-475E-A051-510C083A742CQ33975195-A936915D-4506-40FD-87A6-C4182801AEF2Q34279067-1847BEF0-56B3-485F-A4E3-C86E2CB51D1CQ34647371-68335502-A84C-4E75-A998-5169FA3D79FFQ35124699-275FB152-B739-4122-81A9-6F0009CACFD3Q35412664-8B9E9D6D-6F14-41ED-AF1E-C7EBA7DF22BCQ35420431-06EBAB12-37CB-4400-A20E-3B025320354BQ35562905-EA33DAC2-1F84-4623-99BE-FF19E26BA3D6Q35605786-3FE0F3DA-2109-45C1-A25E-EC994F57A7BDQ35846800-1FF932A3-E366-4EB9-88D6-981F4D623675Q35977675-29093985-6D92-438C-BE20-099EA90115AAQ36147431-60D39DAF-4F7F-4969-993D-2BF2585A2619Q36224836-8F2FB04D-748B-4B86-8D3A-FFDFF99B3C09Q36907139-8BF76425-6E70-4EF4-9042-D10AA422F161Q36939205-28A901DB-6545-4937-9C9F-E95933D73B87Q36953385-677A6F66-B2B8-4F33-A24C-864CCAA98185Q37125483-D9765419-CEB3-4C95-A36E-5789D2679EC2Q37389360-1731D6C0-7FF0-4B43-959B-E8D6D14595BBQ37606629-1AAEF023-3CCB-45A8-859B-90C96F7C2843Q37713320-13B427B0-6599-4C43-BD3A-1711CEEED393Q37728922-0881884B-0E8E-4A68-95C2-D12070327C5EQ37739797-3F1C64A9-33C2-4E0F-9BAD-C1222C3D354FQ37876420-89341CC8-D71C-4581-B1C1-84141007620DQ37943851-22FEEF89-6C4D-40D0-B373-EDAFE9835F44Q37962297-3E48A4CF-07C1-472B-A4EE-48DD93885324Q37981769-757C5223-83C3-47C5-A8DB-E3C48063D784Q38008364-1684AC2D-CE83-48EE-8D6D-AB9B079D85E4Q38074434-AD22E21D-EBD4-4510-978A-CC28A4947318Q38097499-5B4C9C8C-8AA1-40A2-AE7F-07A74507CA2CQ38121569-F3418696-F4DB-4F99-BB64-119FE5CF7C8AQ38161561-CE0430DB-0475-463C-91BA-0CA8F70187E5Q38175951-CAE806A8-7E78-4FF9-9917-D7E9AF3ACBABQ38195641-192647C5-BA21-4D72-910F-0F403965EE3DQ38209324-6882F901-4869-4697-B062-56A86824D440Q38430661-9654697C-99DC-449E-BBE8-AFB32513D201
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Current views of toll-like receptor signaling pathways.
@en
Current views of toll-like receptor signaling pathways.
@nl
type
label
Current views of toll-like receptor signaling pathways.
@en
Current views of toll-like receptor signaling pathways.
@nl
prefLabel
Current views of toll-like receptor signaling pathways.
@en
Current views of toll-like receptor signaling pathways.
@nl
P2860
P356
P1476
Current views of toll-like receptor signaling pathways.
@en
P2093
Kiyoshi Takeda
Masahiro Yamamoto
P2860
P304
P356
10.1155/2010/240365
P577
2010-12-14T00:00:00Z